prostavasin 20 micrograms powder for solution for infusion
ucb pharma gmbh - Алпростадил - 20 micrograms powder for solution for infusion
xyzal 5 mg film - coated tablets
ucb pharma gmbh - Левоцетиризин - 5 mg film - coated tablets
xyzal 5 mg/ml oral drops, solution
ucb pharma gmbh - Левоцетиризин - 5 mg/ml oral drops, solution
moex 7,5 mg film - coated tablets
ucb pharma gmbh - moexipril - 7,5 mg film - coated tablets
moex 15 mg film - coated tablets
ucb pharma gmbh - moexipril хидрохлорид - 15 mg film - coated tablets
zyrtec 10 mg film - coated tablets
ucb pharma gmbh - Цетиризин - 10 mg film - coated tablets
zyrtec 10 mg/ml oral drops, solution
ucb pharma gmbh - Цетиризин - 10 mg/ml oral drops, solution
perlinganit loesung 1 mg/ml solution for infusion
ucb pharma gmbh - Глицерил trinitrate - 1 mg/ml solution for infusion
zyrtec - d 5 mg/120 mg prolonged - release tablets
ucb pharma gmbh - Цетиризин - 5 mg/120 mg prolonged - release tablets
fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - Противоэпилептические средства, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.